3D Systems, Rock Hill, South Carolina, USA, has announced that Andrew Johnson, the company’s executive vice president, Chief Legal Officer, is taking on expanded responsibilities as Chief Corporate Development Officer. In this role, he will continue to lead the company’s mergers & acquisitions and lead the establishment of expanded strategic partnerships.
Johnson has been with 3D Systems for more than sixteen years, during which he led over sixty M&A transactions for the company and played a role in the development of several strategic partnerships. Johnson holds a BA from Miami University, an MBA from the Ross School of Business at the University of Michigan, and a JD from the University of Virginia.
Johnson’s responsibilities will span the entire range of the company’s interests. One of the key emerging areas that he is expected to address is the increasing partnership opportunities 3D Systems now has in regenerative medicine, thereby accelerating its growth in this market.
“Our core strength as a company, one that differentiates us from our competitors, is our relentless application focus in meeting our customers’ most important challenges,” stated Dr Jeffrey Graves, president and CEO. “To be effective in this approach, it is essential for us to be the leader in bringing to bear a broad range of core printing technologies, from metals to polymers and biologics, in combination with market-leading materials and software solutions.”
“To do this on an ever-larger scale,” he continued, “we must increasingly seek strategic partnerships, ranging from basic technology to commercial channels to market. This activity is essential in order to capitalise on the full spectrum of exciting opportunities that are opening ahead of us, as additive manufacturing enters full-scale production environments. Andy’s experience and knowledge of our company and the industry broadly position him very well for success in this expanded role.”